The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-Pyridylmethyl)-12-(2-hydroxyethyl)-13,14-dihydro-naphthol[2,1-a]pyrrolo[3,4-c]carbazole-5-one ID: ALA460577
PubChem CID: 24964172
Max Phase: Preclinical
Molecular Formula: C30H25N3O3
Molecular Weight: 475.55
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1NCc2c1c1c(c3c2c2ccccc2n3CCO)CCc2cc(OCc3ccccn3)ccc2-1
Standard InChI: InChI=1S/C30H25N3O3/c34-14-13-33-25-7-2-1-6-22(25)27-24-16-32-30(35)28(24)26-21-11-9-20(36-17-19-5-3-4-12-31-19)15-18(21)8-10-23(26)29(27)33/h1-7,9,11-12,15,34H,8,10,13-14,16-17H2,(H,32,35)
Standard InChI Key: XAEWMTBGJIPPHH-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 42 0 0 0 0 0 0 0 0999 V2000
-5.3437 -22.8238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4340 -23.6430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7707 -24.1290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5942 -22.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9299 -22.9740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0191 -23.7970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2640 -24.1363 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.1195 -22.8047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7111 -23.5239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4682 -22.8154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8873 -23.5296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4806 -24.2455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6532 -24.2537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6424 -22.8173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2380 -23.5385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5870 -23.5479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0084 -22.8368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5990 -22.1148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2246 -22.1089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0951 -24.9407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7054 -22.0940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8802 -22.0992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6201 -21.3161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2847 -20.8267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9553 -21.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8369 -21.0673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8303 -22.8447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3140 -25.1965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1450 -26.0008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2322 -23.5607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8016 -24.2609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9792 -24.2341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5487 -24.9333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9397 -25.6571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7657 -25.6775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1923 -24.9775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15 16 1 0
8 5 1 0
16 17 2 0
1 2 2 0
17 18 1 0
5 4 2 0
18 19 2 0
19 14 1 0
8 9 2 0
7 20 1 0
21 22 2 0
9 11 1 0
10 22 1 0
21 8 1 0
10 11 2 0
4 1 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 21 1 0
5 6 1 0
23 26 2 0
17 27 1 0
2 3 1 0
20 28 1 0
10 14 1 0
28 29 1 0
11 12 1 0
27 30 1 0
12 13 1 0
30 31 1 0
13 15 1 0
31 32 2 0
3 6 2 0
32 33 1 0
6 7 1 0
33 34 2 0
14 15 2 0
34 35 1 0
7 9 1 0
35 36 2 0
36 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 475.55Molecular Weight (Monoisotopic): 475.1896AlogP: 4.77#Rotatable Bonds: 5Polar Surface Area: 76.38Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.76CX Basic pKa: 3.78CX LogP: 4.09CX LogD: 4.09Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.38Np Likeness Score: -0.27
References 1. Hudkins RL, Diebold JL, Tao M, Josef KA, Park CH, Angeles TS, Aimone LD, Husten J, Ator MA, Meyer SL, Holskin BP, Durkin JT, Fedorov AA, Fedorov EV, Almo SC, Mathiasen JR, Bozyczko-Coyne D, Saporito MS, Scott RW, Mallamo JP.. (2008) Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models., 51 (18): [PMID:18714982 ] [10.1021/jm8005838 ]